1. Home
  2. BCTXZ vs SAX Comparison

BCTXZ vs SAX Comparison

Compare BCTXZ & SAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BCTXZ

BriaCell Therapeutics Corp. Warrant

N/A

Current Price

$0.13

Market Cap

0.0

Sector

N/A

ML Signal

N/A

SAX

Saratoga Investment Corp 8.00% Notes due 2031

N/A

Current Price

$24.97

Market Cap

0.0

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
BCTXZ
SAX
Founded
N/A
N/A
Country
Canada
United States
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
2025
2006

Fundamental Metrics

Financial Performance
Metric
BCTXZ
SAX
Price
$0.13
$24.97
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
27.6K
21.1K
Earning Date
N/A
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.36
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.06
$24.72
52 Week High
$0.52
$25.18

Technical Indicators

Market Signals
Indicator
BCTXZ
SAX
Relative Strength Index (RSI) 74.91 74.36
Support Level $0.26 $24.86
Resistance Level $0.38 $24.99
Average True Range (ATR) 0.04 0.06
MACD 0.00 0.01
Stochastic Oscillator 100.00 92.86

Price Performance

Historical Comparison
BCTXZ
SAX

About BCTXZ BriaCell Therapeutics Corp. Warrant

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

Share on Social Networks: